Cite

HARVARD Citation

    Dumitriu, B. et al. (2016). Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet. 3 (1), pp. e22-e29. [Online]. 
  
Back to record